ZTF vs. VCT, SCPA, ESNT, TET, SYNT, IOF, HAYD, WCH, ITX, and DCTA
Should you be buying Zotefoams stock or one of its competitors? The main competitors of Zotefoams include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Synthomer (SYNT), Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.
Zotefoams vs. Its Competitors
Victrex (LON:VCT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.
Victrex has a net margin of 10.81% compared to Zotefoams' net margin of 7.45%. Zotefoams' return on equity of 8.42% beat Victrex's return on equity.
In the previous week, Victrex and Victrex both had 1 articles in the media. Zotefoams' average media sentiment score of 1.45 beat Victrex's score of -0.13 indicating that Zotefoams is being referred to more favorably in the news media.
Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.
Victrex presently has a consensus price target of GBX 822, suggesting a potential upside of 27.84%. Zotefoams has a consensus price target of GBX 540, suggesting a potential upside of 32.68%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts plainly believe Zotefoams is more favorable than Victrex.
75.5% of Victrex shares are held by institutional investors. Comparatively, 29.0% of Zotefoams shares are held by institutional investors. 4.1% of Victrex shares are held by company insiders. Comparatively, 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Victrex has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Zotefoams has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.
Victrex pays an annual dividend of GBX 0.60 per share and has a dividend yield of 0.1%. Zotefoams pays an annual dividend of GBX 0.07 per share and has a dividend yield of 0.0%. Victrex pays out 1.8% of its earnings in the form of a dividend. Zotefoams pays out 6.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Victrex is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Victrex beats Zotefoams on 9 of the 17 factors compared between the two stocks.
Get Zotefoams News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZTF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ZTF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zotefoams Competitors List
Related Companies and Tools
This page (LON:ZTF) was last updated on 10/20/2025 by MarketBeat.com Staff
